Josef Kittler, University College London, UK
Chris McBain, National Institutes of Health, USA
Beverley Orser, University of Toronto, Canada
Bernhard Luscher, Penn State University, USA
Istvan Mody, The David Geffen School of Medicine at UCLA, USA
The 24th Neuropharmacology Conference 2014 will be held in Arlington, VA, USA from 13-14 November 2014, under the theme: GABAergic Signaling in Health and Disease.
GABAergic signaling plays a critical role in regulating neuronal development, neuronal plasticity and dynamic network behaviour. GABA receptors are also key clinical targets and disrupted inhibition is implicated in a host of neurological and psychiatric disorders including epilepsy, stroke, neurodegeneration, schizophrenia and depression.
Understanding the molecular and cellular events that underpin inhibitory control of neuronal function is therefore central to understanding both brain information processing and brain pathology.
The aim of this two-day meeting is to bring together an international group of junior and senior scientists working on GABA and inhibition to discuss the latest findings in the field.
World experts will present their most recent discoveries covering a broad array of topics from the formation and plasticity of inhibitory synapses, through to GABA receptor structure and function and regulation by endogenous and exogenous modulators. The central role of interneurons for coordinating network behaviour and pathology will also be a key focus.
Abstract submissions are invited on the following conference topics and should be submitted using the online submission system: